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Lethal Attack on Lethal Injection: A Proposal to End the 
Final Loophole in the Death Penalty Debate  
Jasmine Sharma* 
INTRODUCTION 
 
This Note addresses a very controversial topic in our criminal justice 
system: capital punishment by lethal injection. Since 2017 state 
corrections have become desperate to get their hands on lethal injection 
drugs to continue with execution timelines.1 As European and other 
developed nations have come out against capital punishment in their own 
systems and admonished the United States for continuing to execute death 
row inmates,2 large drug manufacturers have followed suit for strategic 
business reasons, as well as moral and ethical considerations.3 As large 
drug manufacturers, which are subject to the FDA regulations standards, 
refused to sell lethal injection drugs to state corrections that were 
executing inmates, state corrections reacted in a myriad of ways. First, 
state corrections attempted to get compounding pharmacies, which are 
pharmacies that are only subject to state licensing boards that mix and 
compound generic drugs, to make lethal injection drugs to execute 
inmates.4 Unsurprisingly, since compounding pharmacies are not subject 
to FDA regulations, the drugs that these compounding pharmacies release 
into the public are less safe as a result of fewer regulations and more 
unsafe practices.5 These unsafe practices have led to many botched and 
highly controversial executions.6 Second, state legislatures and other state 
leaders attempted to shield their lethal injection protocols, including the 
 
*. J.D. 2019, Washington University School of Law. 
1.  Garrett Epps, Arkansas Wants to Execute Seven Inmates Before Their Drugs Expire, ATLANTIC 
(April 13, 2017), https://www.theatlantic.com/politics/archive/2017/04/arkansas-wants-to-execute-
seven-inmates-before-their-drugs-expire/522861/. See infra note 33. 
2.  Editorial, Europe’s View of the Death Penalty, N.Y. TIMES (May 13, 2001), 
http://www.nytimes.com/2001/05/13/opinion/europe-s-view-of-the-death-penalty.html.  
3.  Adam Gabbatt & David Batty, Danish Firm Lundbeck to Stop US Jails Using Drug for Lethal 
Injections, GUARDIAN (July 1, 2011), https://www.theguardian.com/world/2011/jul/01/lundbeck-us-
pentobarbital-death-row.  
4.  Compounding Pharmacies and Lethal Injection, DEATH PENALTY INFO. CTR., 
https://deathpenaltyinfo.org/compounding-pharmacies (last visited Oct. 19, 2017). 
5.  Kevin Outterson, Regulating Compounding Pharmacies after NECC, 367 NEW ENG. J. MED. 
1969 (2012), http://www.nejm.org/doi/full/10.1056/NEJMp1212667#t=article.  
6.  See infra notes 77–81, 193.  
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types of drugs they use, how they were made, and where they come from 
under broad secrecy laws within each jurisdiction.7 This meant that 
inmates who sued under the First Amendment for the right to know what 
substance was used to execute them were unsuccessful.8  
This Note discusses how state corrections have tried to obtain drugs 
from precarious sources. This Note also proposes to close loopholes that 
have allowed executions to continue and to eventually eliminate the 
supply of lethal injection drugs. These loopholes refer to the fact 
corrections are able to bypass federally regulated lethal injection drugs of 
major drug manufacturers and gain access through compounding 
pharmacies. This Note recommends that just as Congress passed an act to 
increase federal regulation of compounding pharmacies after controversial 
outbreaks, Congress should also increase federal regulation of 
compounding pharmacies that sell lethal injection drugs to state 
manufacturers. This provision would have to overcome state secrecy laws 
and require compounding pharmacies to register with the FDA. This 
would subject the drugs to oversight and safer testing mechanisms.  
The first part of this Note delves into the history of the death penalty by 
lethal injection, the most preferred and popular form of execution in the 
United States by state corrections and state legislatures alike. It will delve 
into the roles of drug manufacturers, state corrections, compounding 
pharmacies, as well as the Federal Drug Administration in ending the 
death by lethal injection. The second part of this Note proposes that 
Congress should pass legislation in order to make compounding 
pharmacies that sell to state corrections subject to federal regulations. This 
proposal would protect inmates’ First Amendment rights, make safer 
drugs, and protect the legitimacy of interstate commerce that should be 
subject to FDA regulation. The third part of the Note concludes by 
analyzing other loopholes that may exist and where the death penalty is 
likely to exist in the foreseeable future. Thus, lifting the veil of secrecy, 
forcing compounding drugs to be subject to federal regulation, as well as 
monitoring the use of these drugs would obviate a practical end to death 
 
7.  Josh Sanburn, States Try Secrecy to Protect Lethal Injection Drugmakers, TIME (Oct. 1, 2014), 
http://time.com/3450777/ohio-lethal-injection-secrecy-law-drugs/.  
8.  Id.  
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by lethal injection. The Note then concludes with areas of necessary 
further research.  
 
 
I. GENESIS OF LETHAL INJECTION AS A METHOD OF 
PUNISHMENT 
 
Death by lethal injection is supposedly the most sterile method of 
execution, which may explain its place as a standard method of execution 
in the United States.9 While execution by lethal injection had been 
popularized in the late 19th century10 and World War II, it was not until the 
late 20th century that lethal injection became a viable method of execution 
in the United States.11 Lethal injection as a method of execution was first 
used by Texas in 198212 after Oklahoma became the first state to enact 
legislation adopting such a method to execute prisoners.13 Other states 
quickly followed and adopted lethal injection proposals, which included 
three drugs in a specific sequence: a barbiturate14 to anesthetize the 
prisoner, panicuronium bromide to paralyze the prisoner, and potassium 
 
9.  Kate Pickert, A Brief History of Lethal Injection, TIME (Nov. 10, 2009), 
http://content.time.com/time/nation/article/0,8599,1815535,00.html. Other methods of execution have 
included electrocution, gas inhalation, hanging, and firing squad. Id. Since 1977, 936 out of 1,107 U.S. 
prisoners have been executed by lethal injection. Id. Since 2000 only 5 inmates have died by the 
electric chair. Id. There are a few states that still have the option of other methods of execution. Id. For 
example, Utah allows for execution by firing squad, Washington allows for execution by hanging, and 
Arizona allows for execution by gas. Id.  
10.  Id. A New York commission on capital punishment suggested injecting drugs as a more humane 
alternative to executing prisoners but it was later rejected over public concerns it would cause a public 
scare over associating drug injections with the hypothermic needle. Id.  
11.  Id. The Nazis during World War II used lethal injection as a way of getting rid of sick and 
disabled prisoners in concentration camps during World War II. Id. After World War II the United 
Kingdom proposed and rejected death by lethal injection because of concerns from the medical 
community. Id. 
12.  Id. Texas executed Charles Brooks for murdering a mechanic named David Gregory. Id.  
13.  Id. A medical examiner named Jay Chapman proposed the three-drug protocol. Id. His proposal 
was popular because it avoided concerns of the inmates catching on fire from the execution chair and 
made it easier on witnesses who would executions. Id.  
14.  Id. The most popular bartibuate, type of sedative or sleep inducing drug, that state corrections 
like to use is sodium thiopental. Matt Ford, Can Europe End the Death Penalty in America?, 
ATLANTIC (Feb 18, 2014), https://www.theatlantic.com/international/archive/2014/02/can-europe-end-
the-death-penalty-in-america/283790/. Sodium thiopental has a shelf life of about four years, which 
makes stockpiling the drug extremely difficult. Id. 
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chloride to stop the heart of the prisoner.15 Since then, lethal injection has 
become the standard method of execution for prisoners who receive the 
death penalty.16 
Today, capital punishment has become an impediment in diplomatic 
circles for the United States.17 World leaders have criticized the United 
States for its continued use of the death penalty.18 Meanwhile, the 
European Union has enshrined its disapproval of capital punishment by 
refusing extradition of individuals that could be sentenced to death.19 It 
was abolished in Germany, Austria, and Italy immediately following 
World War II.20 The United States is one of the few countries that continue 
to use the death penalty.21  
 
II. CHALLENGES TO LETHAL INJECTION 
 
Death row inmates in Baze v. Rees22 brought one of the first challenges 
to lethal injection. In Baze, the Supreme Court agreed to review 
Kentucky’s lethal injection protocol. The Supreme Court held the protocol 
was consistent with the Eighth Amendment23 because the petitioners failed 
 
15.  Ford, supra note 14. A simpler, one-drug protocol was also proposed but was rejected because it 
too-closely modeled the method of killing animals. Id.  
16.  Pickert, supra note 9 The basic method for executing prisoners via lethal injection has remained 
relatively consistent. Id. The prisoner is strapped to a gurney with intravenous lines through their arms. 
Id. An employee or medical professional administers the drug in another room as witnesses are 
allowed to watch the execution. Id. After given the last rites and an opportunity for final words a 
cardiac monitor indicates when the inmate’s heart has stopped and the prisoner is declared dead. Id.. 
17.  Editorial, supra note 2. Some European countries will refuse to extradite suspected murders, 
will allow other kinds of suspects to stay in their countries, and allow some allies to vote against 
American membership in the United States Human Rights Commission. Id. 
18.  Id. Felix Rohatyn, an ambassador to France during Clinton’s presidency, said French audiences 
would constantly ask him about America’s continued use of the death penalty. Id. Frequent use of the 
death penalty hurts United States legitimacy as a global moral leader. Id. 
19.  Id. The European Union will not admit any new country that executes criminals and adheres 
strongly to promoting anti-death penalty protocols in its foreign relations. Id.  
20.  Id. Slowly, European Nations abolished use of the death penalty and signed treaties to enshrine 
their moral displeasure of the death penalty. Id. 
21.  Death Penalty 2015: Facts and Figures, AMNESTY INT’L (April 16, 2016, 6:05 PM), 
https://www.amnesty.org/en/latest/news/2016/04/death-penalty-2015-facts-and-figures/. Currently 22 
other countries still use the death penalty as a method of punishment, as of 2014. Id. Some include 
Iran, Pakistan and Saudi Arabia. Id.  
22.  553 U.S. 35 (2008).  
23.  Id. Justice Stevens’ concurrence is often cited in modern anti-death penalty litigation.  He 
https://openscholarship.wustl.edu/law_journal_law_policy/vol59/iss1/16
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to show that the implementation created a “demonstrated risk of severe 
pain.”24 After the Supreme Court ruled Kentucky’s protocol constitutional 
in Baze, states attempted to quell litigation even though their inconsistent 
modifications to their own protocols did not resemble that of the Kentucky 
protocol.25 States’ protocols that attempted to match Kentucky’s protocol, 
which included sodium thiopental, was upheld. 26   
While the Supreme Court has yet to reject death as a form of 
punishment in the United States, much of society and drug manufacturers 
have refused to contribute to lethal injection promulgation.27 Many 
European countries have also been strong opponents of the death penalty.28 
As European countries opposed the death penalty, attitudes in the United 
States started to change as well.29 Drug companies that originally supplied 
the lethal injection drugs to state corrections started to heed to public 
pressure, and refused to supply these drugs to execute prisoners.30 In 2011, 
Lundbeck, a Copenhagen pharmaceutical company, stopped the sale of 
pentobarbital.31 Vince Cable, the Secretary of State for Business, 
Innovation and Skills in the UK from 2010 to 2015, further banned the 
exportation of the sodium thiopental.32 In 2009, Hospira, an Illinois based 
 
argued that imposing the death penalty would constitute “pointless and needless extinction of life with 
only negligible social or public returns.” Id. at 87 (Stevens, J., concurring).  
24.  Id. at 61.  
25.  Deborah W. Denno, Lethal Injection Chaos Post-Baze, 102 GEO. L.J. 1331, 1358 (2014). Here, 
Denno studied 300 cases citing Baze, revealing that states have tried modifying their protocols to quell 
litigation. Id. They did so haphazardly and inconsistently. Id. at 1331. 
26.  Baze, 553 U.S. at 53.  
27.  See infra text accompanying note 31. 
28.  Ford, supra note 14. The European Union guidelines called for the complete abolition of the 
death penalty to contribute to “the enhancement of human dignity and the progressive development of 
human rights.” Id. European Union agencies contribute millions of dollars in donations to anti-death 
penalty organizations and frequently petition state governors and state parole boards to halt executions. 
Id. 
29.  Id.  
30.  Id.  
31.  Gabbatt & Batty, supra note 3. Lundbeck, Danish drug manufacturer, required U.S. distributors 
to sign an agreement that they will not sell their drugs, namely pentobartial (a drug used to treat 
epileptic seizures), to state corrections. Id.  
32.  Peter Walker, Vince Cable Restricts Export of Drug Used in US Executions, GUARDIAN (Nov. 
29, 2010), https://www.theguardian.com/science/2010/nov/29/sodium-thiopental-export-restrictions. 
While the drug has legitimate pain medical uses, a “licence will have to be obtained every time the 
drug is exported and will be refused if the business department has any suspicions it is destined…for 
the execution chamber.” Id. 
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pharmaceutical company, refused to continue producing sodium 
thiopental.33 While initially citing problems with raw-material suppliers, 
the company eventually cited concerns with continuing to supply lethal 
injection drugs for moral reasons.34 Since sodium thiopental became more 
difficult for state corrections to acquire as a result of restricted access, 
states started changing the original three-drug protocol by using 
pentobarbital instead of sodium barbital.35 After Lundbeck imposed 
further controls on pentobarbital as an anesthetic in drug protocols, states 
started using a one-drug protocol of propofol, another anesthetic.36 
However, shortly thereafter, many drug makers like Fresenius Kabi, Teva, 
and Hospira started restricting their distribution of propofol in their use in 
executions.37 Arkansas changed their drug protocols to another one-drug 
protocol using phenobarbital.38 About a month later, the drug company 
Hikma placed heavy controls on the sale of phenobarbital after learning 
state corrections were using their drug in their one-drug protocol .39 As a 
 
33.  Nathan Koppel, Drug Halt Hinders Executions in the U.S., WALL ST. J (Jan. 22, 2011), 
https://www.wsj.com/articles/SB10001424052748704754304576095980790129692. Hospira was 
receiving extreme pressure from activist groups who were protesting their production of lethal 
injection drugs. Id. Their final decision to halt lethal injection production came in the face of 
opposition by the Italian government, where Hospira was planning on putting the new pharmaceutical 
plant. Id.  
34.  Press Release, Hospira, Hospira Statement Regarding Pentothal (Sodium Thiopental) Market 
Exit (Jan. 21, 2011), http://phx.corporate-ir.net/phoenix.zhtml?c=175550&p=irol-
newsArticle&ID=1518610.   
35.  Id. In 2010, Oklahoma became the first state to execute an inmate using pentobarbital. Lincoln 
Caplan, The End of the Open Market for Lethal-Injection Drugs, NEW YORKER (May 21, 2016), 
https://www.newyorker.com/news/news-desk/the-end-of-the-open-market-for-lethal-injection-drugs.   
36.  Caplan, supra note 35. Missouri was the first state to replace the their three-drug protocol with 
the one-drug propofol protocol. (I don’t see Missouri listed) Id. Eight states have used a single-drug 
method for executions and six other have announced they plan to use the one-drug protocol. State by 
State Lethal Injection, DEATH PENALTY INFORMATION CENTER, https://deathpenaltyinfo.org/state-
lethal-injection (last visited Oct. 19, 2017). 
37.  Caplan, supra note 35.  
38.  Caplan, supra note 35. 
39.  Use of Products in Capital Punishment, HIKMA, https://www.hikma.com/about/our-
policies/use-of-products-in-capital-punishment/ (last visited Oct. 21, 2018). Hikma, a British 
pharmaceutical company, sent out an official press release in order to appease their investors and 
customers. Id. “[W]e will not accept orders for these products directly from any Departments of 
Correction or correctional facilities in the United States, unless accompanied by an original, raised seal 
copy of an affidavit signed by the state attorney general (or governor).” Id. See also Ed Pilkington, 
British drug company acts to stop its products being used in US executions, THE GUARDIAN, (May 15, 
2013), https://www.theguardian.com/world/2013/may/15/death-penalty-drugs-us-uk.  
https://openscholarship.wustl.edu/law_journal_law_policy/vol59/iss1/16
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result of this limited supply, state corrections have become desperate40 to 
find lethal injection drugs, drug manufacturers willing to supply these 
drugs, and new creative protocols.41 
 
III. DESPERATE TIMES: USING COMPOUNDING PHARMACIES 
AND FDA OVERSIGHT 
 
As drug manufacturers began to refuse to sell drugs to state corrections, 
states became desperate to get their hands on the drugs. States have 
increasingly used compounding pharmacies in order to stay on schedule 
with executions.42 Compounding pharmacies are traditionally pharmacies 
that mix or alter drugs for individual patients.43 Compounding pharmacies 
must be licensed within their state’s pharmacy board but are not subject to 
FDA regulations.44 While Congress could regulate these compounding 
pharmacies, it is likely compounding pharmacies will continue to operate 
without federal oversight.45 Since compounding pharmacies that provide 
drugs within the same state work intra-state and do not deal with issues of 
interstate commerce, which would subject them to FDA regulation,46 the 
state corrections have been free to utilize these compounding pharmacies 
 
40.  Epps, supra note 1. “Increasingly, states committed to lethal injection behave like addicts 
desperate for another fix. They have resorted to such expedients as interfering with contracts, 
purchasing drugs from sketchy foreign suppliers, and...sending state employees out with bags of cash 
to buy lethal drugs.” Id.  
41.  Id. Substitutions for protocols from a lack of supply of lethal injection drugs “meant that 
inmates were guinea pigs for new forms of lethal injections.” Caplan, supra note 35. In the past few 
years, more than twenty-four drug manufacturing companies have blocked, restricted, or halted the 
sale of lethal injection drugs to state corrections. Id. 
42.  Compounding Pharmacies and Lethal Injection, supra note 4. 
43.  Id.  
44.  Id. Further, compounding pharmacies do not even have to inform the FDA of what drugs they 
are making because of the deference to state oversight over federal oversight when dealing with 
compounding pharmacies. Id.  
45.  Id. Congress passed the Drug Quality and Security Act, which President Obama signed into law 
in late 2013. Id. It allows large-scale compounding pharmacies to be subject to FDA regulations. Id. 
Since compounding pharmacies do not produce lethal injection drugs in large-scale quantities, this 
statute is unlikely to affect the lax state regulation of compounding pharmacies. Id. Further, this law 
was promulgated in an effort to protect health and safety, which illustrates legislative understanding of 
the health risks of compounding pharmacies. (not supported) Id.  
46.  See Anna B. Laakman, Customized Medicine and the Limits of Federal Regulatory Power, 19 
VAND. J. ENT. & TECH. L. 285, 288 (2016) (noting that “[the FDA’s authority] falls short of the outer 
limits of the federal commerce power”). 
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for lethal injections, under the protection of secrecy laws.47 While 
compounding pharmacies are usually accredited, it is not required that a 
compounding pharmacy be accredited to compound drugs, including those 
used in lethal injection.48 Even when accredited, the attendant procedures 
are significantly less cumbersome than FDA regulations, which raise 
serious concerns about the safety of compounding pharmacies and its 
subsequent use in executions.49 
Specifically, federal authority to regulate compounding pharmacies 
stems from the Food, Drug, and Cosmetic Act (FDCA).50 In 1997, 
Congress amended the statute to address concerns that compounding 
pharmacies were acting under the guise of manufacturers and were 
attempting to thwart federal regulation.51 The new amendments allow 
compounding pharmacies to avoid FDA regulation if they meet three of 
the FDCA provisions.52 The FDCA is inapplicable to drug compounding 
pharmacies that comply with provisions on (1) the sale of a “new drug,” 
(2) adulteration and the need to adhere to “good manufacturing practices,” 
and (3) misbranding and the need to provide “adequate directions for 
use.”53 There are many requirements that FDA applies to compounding 
pharmacies once under federal regulation.54 Specifically, the FDA requires 
the compounded drugs to be made of FDA approved ingredients, it 
 
47.  Id. 
48.  Id.  
49.  Id. A compounding pharmacy in 2012, called The New England Compounding Center, was the 
center of a scandal where it was the site of a fungal meningitis outbreak, which infected over 700 
people in 20 states. Id.  63 people died from that outbreak. Id. The pharmacy was unaccredited and 
was only subject to state regulation. Id.  
50.  Pub. L. No. 75-717, 52 Stat. 1040 (1938) (codified as amended at 21 U.S.C. § 301 et seq.); 
ANDREW NOLAN,  CONG. RESEARCH SERV., R43038, FEDERAL AUTHORITY TO REGULATE THE 
COMPOUNDING OF HUMAN DRUGS 2 (2013).  
51.  Id. at 5. Congress amended the FDCA through the Food and Drug Administration 
Modernization Act (FDAMA). Id. Specifically, the FDA was concerned “some pharmacists were 
manufacturing and selling drugs under the guise of compounding,” as a way of avoiding the FDCA’s 
“new drug,” “adulteration,” and “misbranding” provisions.” Id.  
52.  Id.  
53.  Id. at 5–6. Meeting these provisions would not(?) make a compounding pharmacy subject to the 
FDCA. Id. 
54.  See id. at 6. A licensed physician must compound the drugs in response to a valid prescription 
for an individual patient. Id. If the drug is not compounded in response to a prescription, it must be 
made in “limited quantities” and in response to a “history of the licensed pharmacist’s or physician’s 
receipt of valid prescription orders for that drug product within an established relationship between the 
pharmacist, the patient, and the prescriber.” Id.  
https://openscholarship.wustl.edu/law_journal_law_policy/vol59/iss1/16
SHARMA NOTE   8/7/19 
 
 
 
 
 
 
 
 
 
2019]  Lethal Attack on Lethal Injection 309 
 
 
prohibits drugs that appear on the list of withdrawn or removed products, 
prohibits drugs compounded in “inordinate amounts,”55 and allows the 
FDA to identify and prohibit unsafe and ineffective products.56  
While Congress has attempted to remedy the safety concerns that 
emanate from compounding pharmacies that manufacture drugs in bulk, it 
does not adequately address the lack of safety when compounding 
pharmacies make individualized drugs for state corrections.57 Further, 
there are other loopholes within the FDCA that allow compounding 
pharmacies that make lethal injection drugs to sell to state corrections.58 
Other than safety, there are many other policy levers that weigh in favor of 
enhancing state regulation.59 While states have raised many First 
Amendment concerns over the promulgation of 503A of the FDCA, the 
provision of the FDCA that “describes the conditions that must be satisfied 
for human drug products compounded by a licensed pharmacist in a State 
licensed pharmacy or Federal facility”,60 there are many reasons to extend 
 
55.  Id. The FDAMA aims to prohibit compounding in “inordinate amounts” in order to make the 
drugs “essentially copies of a commercially available drug product.” Id. 
56.  Id. 
57.  Sabrina Tavernise, Bill on Drug Compounding Clears Congress a Year After a Meningitis 
Outbreak, N.Y. TIMES (Nov. 18, 2013), http://www.nytimes.com/2013/11/19/us/bill-on-regulating-
drug-compounding-clears-senate.html?_r=1&. A year after the meningitis outbreak in the New 
England compounding pharmacy, Congress passed a bill to increase federal oversight of compounding 
pharmacies. Id. The bill does not force companies to register with the FDA. Id. The bill called the 
“Drug Quality and Security Act” allows compounders that mass-produce compounded drugs to 
register with the FDA as “outsourcing facilities.” Id. Under this law they would be subject to some 
federal regulation. Id. However, those companies that continue to produce under a narrower definition 
of compounding, i.e. “mixing medicines for individual patients, or limited quantities” would not be 
subject to the federal oversight and are not required to register with the FDA. Id.  
58.  See Outterson, supra note 5. “Section 503A provided a test for distinguishing between the two: 
it limited interstate shipments to no more than 5% of the compounder's business, unless the home state 
had entered into a ‘memorandum of understanding’ with the FDA, bolstering state and federal 
cooperation.” Id. at 1971.  
59.  Id. at 1971–72.  
 
Other policy levers that may be needed include enhanced transparency for state-level 
regulation, mandatory disclosures to physicians and patients, mandatory reporting of 
adverse events, user fees to support oversight, clear FDA authority to register and inspect 
nontraditional compounding pharmacies, enhanced incentives for internal whistleblowers, 
and modification of reimbursement rules to blunt the economic incentives driving 
industrial-scale compounding. 
 
Id.  
60.  Prescription Requirement Under Section 503A of the Federal Food, Drug, and Cosmetic Act: 
Washington University Open Scholarship
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federal regulation over compounding.61 Such reasons include enhanced 
safety and monitoring of these powerful barbiturates.   
 
IV. CHALLENGES TO FDA REGULATION OF COMPOUNDING 
PHARMACIES 
 
Courts have also examined the extent of the FDA to regulate 
compounding pharmacies. Very few courts, however, have discussed the 
extent of FDA regulation of compounding.62 According to the plain 
meaning of the statute, “new drug” and “introduce or deliver for 
introduction into interstate commerce any new drug” has broad meaning 
within the FDCA.63 In all three provisions mentioned above, the FDCA 
gives the FDA broad power to regulate compounding pharmacies.64 
Currently, the FDA has a variety of factors to provide guidance for when 
to subject a compounding pharmacy to FDA regulations.65 
 
Guidance for Industry, (December 2016), 
https://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/ 
Guidances/UCM496286.pdf. See also Outterson, supra note 5, at 1971.  
61.  Nolan, supra note 47, at 2. States filed suit for a First Amendment violation over 503A 
advertising provisions that the Supreme Court struck down, see Thompson v. W. States Med. Ctr., 535 
U.S. 357 (2002),  which created a split among federal circuit courts regarding severability and thus the 
continued validity of the federal regulation over compounding pharmacies. Compare Western States 
Medical Center v. Shalala, 238 F.3d 1090, 1097 (9th Cir. 2001), aff’d on other grounds, 535 U.S. 357 
(2002) (finding the provision unseverable) with Medical Ctr. Pharmacy v. Mukasey, 536 F.3d 383, 
401(5th Cir. 2008) (finding the provision severable). 
62.  Id. at 12. So far, FDA has generally declined to test the current limits of federal authority over 
the traditional compounding pharmacies. Id.  
63.  Id.  
64.  Id. at 9–10. This argument is buttressed by the fact “that because exemptions exist under the 
FDCA’s provisions for other types of drugs, such “investigational drugs,” one can presume from 
Congress’s refusal to create a general exemption for traditional compounding an implicit extension of 
federal authority over all forms of compounding.” Id. at 11. 
65.  Id. at 8. Some factors include:  
 “done in anticipation of receiving prescriptions? 
... involving a drug that was withdrawn or removed from the market for safety reasons? 
... based from bulk active ingredients? 
... done without obtaining written assurance from the supplier that the drug substances were 
made in an FDA-registered facility? 
... not in compliance with official compendia requirements? 
... using commercial scale manufacturing or testing equipment? ... done for third parties 
who will resell the drugs? 
... of drug products that are commercially available in the marketplace or essentially copies 
of commercially available drugs? 
https://openscholarship.wustl.edu/law_journal_law_policy/vol59/iss1/16
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The FDA is an important actor within the lethal injection debate. The 
power of the FDA’s discretion came about after a highly controversial 
incident after the supply of lethal injection drugs in Arizona and Georgia 
ran dry.66 This controversy was litigated in Cook v. FDA.67 Between 2010-
2011, the FDA had seized multiple shipments of the lethal injection drug 
sodium thiopental but soon released them to the states to be used in 
executions.68 These drugs were taken from a non-FDA approved foreign 
supplier, Dream.69 Plaintiffs in the suit were death row inmates in Arizona, 
California, and Tennessee who argued the FDA failed its duties under the 
Federal Food, Drug and Cosmetic Act, which makes it unlawful to 
introduce into interstate commerce a misbranded drug70 or unapproved 
drug.71 More specifically, plaintiffs alleged a violation of § 381(a) of the 
FDCA.72 Plaintiffs argue that FDA seized the drugs as per their duties 
 
... failing to comply with applicable state law?”  
 
Id.  
 
These factors are guiding factors for whether the FDA will take action against a compounder of human 
drugs. Id. If answered in the affirmative, the FDA is more likely to asserts its regulatory authority 
against the compounding pharmacy.” Id. 
66.  Denno, supra note 25. See supra notes 13–23 for a discussion on reduced supply of lethal 
injection drugs.  
67.  Cook v. FDA, 733 F.3d 1, 3 (D.C. Cir. 2013). 
68.  Id. at 4. The court cites the FDA statement, where  
[t]he FDA further released a statement ‘that it neither approves nor reviews [thiopental] for 
use in lethal injections.’ Rather, in ‘defer[ence] to law enforcement’ agencies, henceforth it 
would exercise its ‘enforcement discretion not to review these shipments and allow 
processing through [Customs'] automated system for importation.  
Id.  
69.  Id. In fact, Dream Pharma in Britain was a British distributor, which operated out of the back of 
a driving school in the city of London. Ford, supra note 14. 
70.  21 U.S.C. § 331(a) (2018). 
71.  21 U.S.C. § 355(a) (2018). 
72.  Cook, 733 F.3d at 4. The statute provides:  
The Secretary of the Treasury shall deliver to the Secretary of Health and Human Services 
[HHS], upon his request, samples of . . . drugs . . . being imported or offered for import into 
the United States. . . . The Secretary of [HHS] shall furnish to the Secretary of the Treasury 
a list of establishments registered [with the FDA] . . . and shall request that if any drugs . . . 
manufactured, prepared, propagated, compounded, or processed in an establishment not so 
registered are imported or offered for import into the United States, samples of such drugs . 
. . be delivered to the Secretary of [HHS]. . . . If it appears from the examination of such 
samples or otherwise that . . . such article is adulterated, misbranded, or [an unapproved 
new drug] . . . , then such article shall be refused admission. 
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under §381(a) but violated their duties when they released the shipments 
and allowed states to thereafter import thiopental without interference.73 
The court held that the FDA violated the FDCA and violated its duties 
such that:  
 
[T]he FDA acted in derogation of those duties by permitting the 
importation of thiopental, a concededly misbranded and unapproved 
new drug, and by declaring that it would not in the future sample 
and examine foreign shipments of the drug despite knowing they 
may have been prepared in an unregistered establishment.74 
 
The decision in Cook is significant for a variety of reasons. First, it 
further limited the supply of sodium thiopental.75 As a result, states 
continued to experiment with different drugs and different protocols in 
order to continue with their execution schedules, with troubling results.76 
One of the most popular drug that states began to use is midazolam,77 
which is not a barbiturate like sodium thiopental but instead is used to 
relieve anxiety.78 While midazolam became a part of the protocol as early 
as 2009 for some states,79 the drug became a crucial drug in at least six 
states.80  
Recently, the promulgation of lethal injections has become more and 
more concerning.81 As a result of the decision in Cook, the lack of supply 
 
 
21 U.S.C. § 381(a) (2018). 
73.  Cook, 733 F.3d at 5.  
74.  Id. at 11.  
75.  Id. See supra note 41.  
76.  Caplan supra note 35.  
77.  See supra note 73. A recent controversy surrounding midazolam is in Arkansas. See infra note 
78.  The purpose of midazolam is to is to render a prisoner unconscious to keep him from experiencing 
pain later on when the other drugs that are meant to stop the heart and breathing. See infra note 78.  
78.  Alan Blinder, When a Common Sedative Becomes an Execution Drug, N.Y. TIMES (March 13, 
2017), https://www.nytimes.com/2017/03/13/us/midazolam-death-penalty-arkansas.html. Midazolam 
works similarly to valium and is meant to decrease painful side effects. Id.  
79.  Id. Ohio was the first state to include midazolam in its the drug protocol but simply used it as an 
alternative. Id.  
80.  Id. Florida became the first state to use midazolam in its official execution protocol. Id. It also 
became the first state to use midazolam in an actual execution. Id.  
81.  Caplan supra note 35. Currently, at least ten states have used or intent to use compounding 
pharmacies to obtain their drugs for lethal injection death penalty. State by State Lethal Injection, 
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from the embargo by drug manufacturers, and the rise in compounding 
pharmacies not subject to FDA regulations because of dealings of purely 
state matters of execution, there has been an advent of botched 
executions.82 As mentioned above, compounding pharmacies are usually 
less safe because the state licensing regulations are not as stringent as the 
FDA regulations.83 Some examples include the execution of Clayton 
Lockett,84 Ronald Smith,85 Kenneth Williams,86 Dennis McGuire,87 and 
Joseph Wood.88 These are some of the most recent documented examples 
of botched executions, however death row inmates have been executed for 
many years with lethal injections that have been subject to state secrecy 
laws so there could be many more.  
 
 
supra note 36.  
82.  See infra note 87.  
83.  Nolan, supra note 47, at 1. One example of the unsafe nature of compounding pharmacies that 
occur as a result of lax regulations occurred in 2012. Id. A fungal meningitis outbreak, which was 
believed to have been caused by contaminated compounded steroids from a New England 
compounding pharmacy, which was linked to a multistate fungal meningitis outbreak resulting in over 
50 deaths. Id. 
84.  State by State Lethal Injection, supra note 34. Oklahoma used midazolam in the execution of 
Clayton Locket in April 2014. Oklahoma Botches Execution of Clayton Lockett, DEATH PENALTY 
INFORMATION CENTER, https://deathpenaltyinfo.org/node/5760 (last visited Oct. 21, 2018). The state 
administered the midazolam in the three-drug protocol. Id. After he was declared unconscious, 
witnesses claim that he began to seize on the gurney. Id. He died of a massive heart attack 
approximately forty minutes after the midazolam was administered. Id. Further, the midazolam was 
made from a compounding pharmacy. State by State Lethal Injection, supra note 34. See also Jeffrey 
E. Stern, The Cruel and Unusual Execution of Clayton Lockett, THE ATLANTIC, (June 2015), 
https://www.theatlantic.com/magazine/archive/2015/06/execution-clayton-lockett/392069/.   
85.  State by State Lethal Injection, supra note 34. After the state administered the midazolam, 
Ronald Smith spent fifteen minutes of coughing and convulsing on the gurney before he was declared 
dead. Ronald Smith Heaves and Coughs During Alabama Execution After Tie Vote in Supreme Court 
Denies Him Stay, DEATH PENALTY INFORMATION CENTER, https://deathpenaltyinfo.org/node/6623 
(last visited Oct. 22, 2018).   
86.  State by State Lethal Injection, supra note 34. Witnesses report jerking and convulsing at 
Kenneth Williams execution after the midazolam was administered. Id. 
87.  Id. After McGuire’s botched execution, Ohio briefly abandoned its use of midazolam in its 
protocol but opted to bring it back shortly after. Id.  
88.  Id. Joseph Wood gasped after being injected with midazolam and hydromorphone. Arizona 
Botches Execution of Joseph Wood, DEATH PENALTY INFORMATION CENTER, 
https://deathpenaltyinfo.org/node/5828 (last visited Oct. 21, 2018). During the ordeal Mr. Wood’s 
attorneys placed a phone call to Justice Anthony Kennedy in order to halt the execution because he 
Wood was still alive one hour in. Id. A reporter who witnessed the execution said he counted 600 
gasps before Wood was declared dead. Id.  
Washington University Open Scholarship
SHARMA NOTE   8/7/19 
 
 
 
 
 
 
 
 
 
314 Journal of Law & Policy [Vol. 59:301 
 
 
V. HIDING DRUGS AND COMPOUNDING PHARMACIES BEHIND 
SECRET LAWS 
 
As a result of the substantial litigation, drug manufacturers, state 
corrections and subsequent state legislatures have attempted to insulate 
their methods of procuring and compounding the drugs.89 The most 
effective way that states have been able to insulate themselves from 
litigation and public pressure is through the enactment of secrecy laws.90 
These secrecy laws have been implemented to protect state corrections and 
the source of their lethal injection drugs.91 For example, the plaintiffs in 
Cook were able to successfully challenge the source of the drugs to be 
used in their execution – state secrecy laws would obfuscate the source 
and prevent a similar future challenge. Further, these secrecy laws also 
protect modifications of the protocol itself.92 Inmates, newspapers, and the 
ACLU have tried suing state corrections, arguing keeping identity of drugs 
and the compounding pharmacy is a violation of the First Amendment.93  
Further, the cases of Lockett94 and Wood95 resulted in an extremely 
 
89.  See infra note 90 for discussion on secrecy laws.  
90.  Sanburn, supra note 7. States fear backlash of large drug manufacturers as well as activist 
groups. Id.  
91.  Josh Sanburn, Oklahoma Judge Says State Can’t Keep Execution Drugs Secret, TIME, (Mar. 26, 
2014), http://time.com/39232/oklahoma-lethal-injection-drugs-unconstitutional/. Secrecy laws were 
originally implemented in order to protect the physicians in the execution chamber and a variety of 
other medical professionals from being threatened or harassed by the public. Id. States later put 
compounding pharmacies under the umbrella of protection of these secrecy laws. Id.  
92.  Id. For example, Oklahoma ruled in 2014 to lift secrecy laws in order to protect inmates access 
to information. Id. “In addition to protecting drug makers’ anonymity, Oklahoma changed its drug 
protocol this week to allow the department of corrections to choose from one of five drug 
combinations after running into difficulty obtaining the necessary chemicals.” Id. Secrecy laws were 
an explicit attempt by state lawmakers to continue with drug protocols deadlines and not receive the 
backlash that drug manufacturers were subject to. Id.   
93.  Sanburn, supra note 7. The Guardian, AP, and Missouri’s largest three newspapers sued 
Missouri Department of Corrections arguing that it was a violation of the First Amendment to keep the 
different drugs and where the state was obtaining the drugs a secret. Id.  
94.  Lockett v. Evans, 330 P.3d 488, 489 (2014). Lockett was in death row for rape and murder. 
Stern, supra note 84. He sought a stay of execution based on the fact the state corrections kept secret 
the identity of the drug, the drug protocol, and the pharmacy to be used in his execution. Id. During the 
subsequent litigation, the execution was delayed after the corrections lacked the lethal injection drugs 
to carry out the execution. Id. The stay proved extremely controversial by the state leaders. Id. The 
Oklahoma Governor indicated she would defy the legislatures and call for the impeaching of the 
justices if they do not lift the stay of execution for Lockett. Id. A few short days later the Oklahoma 
Supreme Court dissolved the stay. Id. 
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dramatic illustration of the secrecy laws. These cases highlight the two 
different kinds of secrecy laws that have been challenged in court – 
confidentiality laws over the source (compounding pharmacies) and 
confidentiality laws over the lethal injection protocol (how the state 
correction will executive the inmate).96 Many litigants have argued that 
these secrecy laws are an attempt to conceal the poor quality of drugs from 
compounding pharmacies.97  
 Further, in the past few years a new controversy has reenergized the 
lethal injection debate. After an investigation by the St. Louis Public Radio 
and St. Louis Beacon regarding a compounding pharmacy, the issue of 
whether compounding pharmacies should be subject to FDA regulation 
arose again.98 The investigation revealed that the pharmacy that the 
Missouri state correction was using was not licensed in Missouri but 
instead licensed in Oklahoma.99 This has opened up a new line in inquiry 
and controversy since Oklahoma and Missouri are now engaged in 
interstate commerce, which opens up the potential to subject to the 
FDA.100 
 
 
95.  Wood v. Ryan, 759 F.3d 1076, 1088 (9th Cir. 2014), preliminary injunction of execution 
vacated sub nom., Ryan v. Wood, 132 S. Ct. 21 (2014). Wood similarly sued the state regarding the 
drug supply confidentiality laws. Id. Less than a month from his execution Wood sued, arguing for a 
stay for the state’s refusal to release the source of the drugs that were to be used in his execution. Id. 
He argued the same constitutional violations that Lockett argued. Id. After the district court denied his 
petition, the Ninth Circuit reversed. Id. Dramatically, the Supreme Court reversed the grant of the stay 
of execution of the Ninth Circuit just a day before the execution and allowed the execution to proceed. 
Id.  
96.  See infra notes 89–90.  
97.  See infra note 57.  
98.  Chris McDaniel & Vernique Lacapra, Investigation: Missouri’s Execution Drug Source Raises 
Legal, Ethical Questions, ST. LOUIS PUBLIC RADIO (Dec. 31, 2013) 
http://news.stlpublicradio.org/post/investigation-missouris-execution-drug-source-raises-legal-ethical-
questions#three. After a shortage of willing drug suppliers had refused to provide the requisite drugs, 
Missouri Governor Jay Nixon directed the state to adopt a new protocol with the use of pentobarbital. 
Pentobarbital, as stated above, is commonly used by veterinarians to euthanize animals. Id. 
99.  Id. A federal judge speaking on the subject called the execution drug a “shadow pharmacy by 
the hangman’s hood.” Id. 
100.  See supra note 71 regarding FDCA “interstate commerce” definition.  
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VI. PROPOSING AN END TO LETHAL INJECTION THROUGH 
FEDERAL REGULATION 
 
This Note proposes a method of ending the death penalty by lethal 
injection because of moral, ethical, and practical implications.101 Further, 
the courts have followed public sentiment towards slowly eradicating the 
death penalty.102 This Note proposes closing the compounding pharmacy 
loophole in a few different ways. This topic is of particular relevance 
given the controversy regarding lethal injection from European 
countries103 and drug manufacturers.104 This Note proposes a multi-
pronged approach in order to eliminate the supply of the lethal injection 
drugs. As mentioned above, there are a multitude of layers that exist that 
make lethal injection drugs a problem. First, after drug manufacturers 
refused to sell lethal injection drugs to state corrections, state corrections 
resorted to compounding pharmacies.105 Further, compounding 
pharmacies, not subject to federal regulation, have resulted in many unsafe 
and botched executions.106 Even further, secrecy laws governed by each 
state jurisdiction protect these compounding pharmacies from judicial 
scrutiny.107  
 First, this Note proposes that the compounding pharmacies that supply 
lethal injection drugs should be subject to federal regulation. As 
mentioned above, the FDCA has “new drug” “adulteration” and 
“misbranding” provisions of a drug transported in interstate commerce.108 
Meeting these provisions would make a compounding pharmacy subject to 
the FDA regulation.109 The government can label compounding 
pharmacies that mix and compound lethal injection drugs to be 
administered to death row as “misbranded”110 or “new drug”111 to make 
 
101.  See supra note 24. Retired Justice Stevens advocates for an eventual end to lethal injection. 
Baze v. Rees, 553 U.S. 35, 87 (2008) (Stevens, J., concurring). 
102.  See Baze, 553 U.S. at 87 (Stevens, J., concurring).  
103.  See supra notes 2–4, 19 and accompanying text.  
104.  See supra note 34. 
105.  See supra notes 36–40. 
106.  See supra notes 70–71.  
107.  See supra notes 72–73. 
108.  See supra note 51. 
109.  See supra note 53. 
110.  See supra note 51. 
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them subject to federal regulation. Essentially, requiring compounding 
pharmacies to ensure the safety and efficacy testing of drugs would be 
economically unfeasible.112 As such, FDA regulation requiring rigorous 
testing113 would effectively eliminate the compounding pharmacies’ desire 
to sell and compound these drugs to state corrections. Moreover, violation 
of these provisions is extremely costly to compounding pharmacies.114 
Further, lessons from the Cook115 case show the Court’s willingness to 
penalize the FDA from refusing to act in accordance for the public benefit 
for compounding pharmacies.116 Specifically, the Cook case shows an 
increased willingness to federally regulate unsafe drugs. While the Cook 
case involved an importation of drugs from the back of the London driving 
school,117 compounding pharmacies show an extreme and real risk.118  
 
VII. PROPOSING AN END TO LETHAL INJECTION THROUGH 
CLOSING THE COMPOUNDING PHARMACY GAP 
 
There are a variety of factors119 that the federal government uses to 
determine whether to regulate a compounding pharmacy. One factor is if it 
“involve[s] a drug that was withdrawn or removed from the market for 
safety reasons.”120 Since each lethal injection drug has been removed from 
the drug manufacturer market as a result of big pharmaceutical companies, 
this factor weighs in favor of regulation. Another factor in favor of 
regulation is whether the compounding is “done without obtaining written 
assurance from the supplier that the drug substances were made in an 
 
111.  See supra note 53–54. 
112.  Exploring the Right Mix to Protect Patients: Hearing on Federal and State Role in Pharmacy 
Compounding and Reconstitution Before the S. Comm. on Health, Educ., Labor, and Pensions, 108th 
Cong. 1 (2003) (statement of Steven Galson, Acting Director, Center for Drug Evaluation and 
Research, U.S. Food and Drug Administration). 
113.  See supra note 53. 
114.  Nolan, supra note 47, at 2. Section 301 of the FDCA allows the government to impose both 
civil and criminal fines to compounding pharmacies. Id. These penalties can be up to $10,000 and 
three years in prison for repeat or knowing violations. See 21 U.S.C. § 333 (2018). 
115.  See supra note 67.  
116.  See supra note 77-81.  
117.  Ford, supra note 14.  
118.  See discussion supra note 49. 
119.  See supra note 65.  
120.  See supra note 60.  
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FDA-registered facility?”121 Here, the compounding pharmacies that 
compound lethal injection drugs are usually made without written 
assurance. Further, they aren’t made in an FDA-regulated facility given 
the secrecy surrounding compounding pharmacy. The last few factors, 
namely whether they have been subject to large scale testing and whether 
done for third parties who will resell the drugs, weigh in favor of federal 
regulation.122 
Additionally, because requiring an inquiry into whether a drug has been 
introduced in interstate commerce123 is a prerequisite into deciding 
whether a drug can be subject to federal regulation, the protection of 
compounding pharmacies behind secrecy laws should be lifted. This Note 
proposes that in order to allow for the public safety over compounding 
drugs, an inquiry into whether or not section 503 applies to extend federal 
regulation into compounding pharmacy.124 However, there are many issues 
over federal regulation of traditional compounding,125 which includes 
generic drugs, small amounts of mixing for prescriptions etc. However, an 
amendment or interpretation of 503A to allow federal regulation over 
nontraditional compounding to protect the safety and efficiency of 
compounded drugs would not interfere with the issues of federalism and 
would strike a balance towards public safety. Further, the language of the 
statute provides the federal government broad regulatory power.126  
 
VIII. A NARROW SOLUTION TO THE LETHAL INJECTION 
DEBATE 
 
This Note proposes that increasing federal regulation over compounding 
pharmacies would effectively mean that, at the very least, the lethal 
injection drugs would have to be subject to more rigorous testing and other 
federal standards. This scrutiny would help to avoid botched executions 
 
121.  See supra note 60.  
122.  See supra note 60.  
123.  See supra note 58.  
124.  Outterson, supra note 5 (explaining that Section 503A has a few limitations for federal 
regulation of compounding drugs). 
125.  See supra note 59.  
126.  See supra note 65. 
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such as those mentioned above.127 Further, in order to regulate these 
compounding pharmacies, secrecy laws that prevent the government and 
the public from knowing the drug protocol128 and which compounding 
pharmacy the drug came from must be lifted. This move would signal the 
legislature that the last loophole for state corrections to receive lethal 
injection drugs has been exhausted. History within the United States 
shows that change within death penalty litigation moves slowly, and this 
proposal of increasing federal regulation, lifting secrecy laws, and making 
it impracticable and relying on public pressure would be the most apt way 
to end capital punishment by lethal injection.  
 
CONCLUSION 
 
The diplomatic cost of the death penalty is high. This Note does not 
argue that compounding pharmacies are bad or should be eliminated given 
their other benefits, it simply proposes a narrow reading to increase the 
safety and hopefully eliminate the unsafe and inhumane lethal injection 
drugs. Further, this Note also does not argue that secrecy laws are 
inherently bad since they have been empirically used to protect 
confidential information and prevents harm of individuals that work within 
the criminal justice system. This Note takes a narrow reading of the 
secrecy laws and opposes those secrecy laws used to hinder the 
constitutional rights of death row inmates, who have been constantly at 
limbo throughout the uncertainty of supply of lethal injection drugs. A 
narrow reading of statutes and laws that are meant to protect the public at 
its face has increasingly been used to thwart safety concerns in order to 
continue with execution timelines.  
The stories of botched executions as well as the death anxiety suffered 
by death row inmates, illuminate the necessity to reform the criminal 
justice system as a modern and humane system.  
Current anti-death penalty efforts should focus on utilizing large actors 
to stress the morality issues as well as the diplomatic problems with the 
death penalty, as mentioned during the history section of this note. Such 
 
127.  See supra notes 84–88 for a discussion on these botched executions.  
128.  See supra note 13; see also supra note 36.  
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large actors with political capital include large drug manufacturers, the 
federal agencies, and pharmacies that have a stake in ending the death 
penalty. Further, another inquiry into other potential gaps by state 
legislatures would further allow an effective end to the lethal injection.  
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